The immune response to primary EBV infection: A role for natural killer cells

British Journal of Haematology

Volumn 129, Issue 2, 2005, Pages 266-274

  Williams, Hilary ^a   McAulay, Karen ^a   Macsween, Karen F ^a   Gallacher, Neil J ^a   Higgins, Craig D ^b   Harrison, Nadine ^c   Swerdlow, Anthony J ^b   Crawford, Dorothy H ^a,c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Human; Natural killer cells; Viral

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; VIRUS DNA;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTIOUS MONONUCLEOSIS; MALE; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIGENS, CD56; BLOOD DONORS; CASE-CONTROL STUDIES; CYTOKINES; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; VIRAL LOAD;

EID: 17644373015     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05452.x     Document Type: Article

References (43)

1. Andersson, U., Martinez-Maza, O., Andersson, J., Britton, S., Gadler, H., De Ley, M. & Modrow, S. (1984) Secretion of gamma-interferon at the cellular level. Induction by Epstein-Barr virus. Scandinavian Journal of Immunology, 20, 425-432.
2. Anonymous (1971) Infectious mononucleosis and its relationship to EB virus antibody. A joint investigation by university health physicians and P.H.L.S. laboratories. British Medical Journal, 4, 643-646.
3. Arase, H. & Lanier, LL. (2002) Virus-driven evolution of natural killer cell receptors. Microbes and Infection, 4, 1505-1512.
4. Arase, H., Mocarski, E.S., Campbell, A.E., Hill, A.B. & Lanier, L.L. (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science, 296, 1323-1326.
5. Benoit, L., Wang, X., Pabst, H.F., Dutz, J. & Tan, R. (2000) Defective NK cell activation in X-linked lymphoproliferative disease. Journal of Immunology, 165, 3549-3553.
6. Biglino, A., Sinicco, A., Forno, B., Pollono, A. M., Sciandra, M., Martini, C., Pich, P. & Gioannini, P. (1996) Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis. Clinical and Immunological Immunopathology, 78, 61-69.
7. Biron, C.A., Nguyen, K.B., Pien, G.G., Cousens, L.P. & Salazar-Mather, T.P. (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annual Review of Immunology, 17, 189-220.
8. Brown, M.H., Boles, K., van der Merwe, P.A., Kumar, V., Mathew, P.A. & Barclay, A.N. (1998) 2B4, the natural killer and T cell immune-globulin superfamily surface protein, is a ligand for CD48. Journal of Experimental Medicine, 188, 2083-2090.
9. Brown, M.G., Dokun, A.O., Heusel, J.W., Smith, H.R., Beckman, D.L., Blattenberger, E.A., Dubbelde, C.E., Stone, L.R., Scalzo, A.A. & Yokoyama, W.M. (2001) Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science, 292, 934-937.
10. + T cells in acute infectious mononucleosis. Nature Medicine, 2, 906-911.
11. Coffey, A.J., Brooksbank, R.A., Brandau, O., Oohashi, T., Howell, G.R., Bye, J.M., Cahn, A.P., Durham, J., Heath, P., Wray, P., Pavitt, R., Wilkinson, J., Leversha, M., Huckle, E., Shaw-Smith, C.J., Dunham, A., Rhodes, S., Schuster, V., Porta, G., Yin, L., Serafini, P., Sylla, B., Zollo, M., Franco, B. & Bentley, D.R. (1998) Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nature Genetics, 20, 129-135.
12. Cooper, M.A., Fehniger, T.A. & Caligiuri, M.A. (2001a) The biology of human natural killer-cell subsets. Trends in Immunology, 22, 633-640.
13. Cooper, M.A., Fehniger, T.A., Turner, S.C., Chen, K.S., Ghaheri, B.A., Ghayur, T., Carson, W.E. & Caligiuri, M.A. (2001b) Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood, 97, 3146-3151.
14. Daniels, K.A., Devora, G., Lai, W.C., O'Donnell, C.L., Bennett, M. & Welsh, R.M. (2001) Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. Journal of Experimental Medicine, 194, 29-44.
15. FehnigiT, T.A., Cooper, M.A., Nuovo, G.J., Cella, M., Facchetti, F., Colonna, M. & Caligiuri, M.A. (2002) CD56bright natural killer cells are present in human lymph nodes and are activated by T cell derived IL-2: a potential new link between adaptive and innate immunity. Blood, 101, 3052-3057.
16. Fleisher, G., Henle, W., Henle, G., Lennette, E.T. & Biggar, R.J. (1979) Primary infection with Epstein-Barr virus in infants in the United States: clinical and serologic observations. Journal of Infectious Diseases, 139, 553-558.
17. Foss, H.D., Herbst, H., Hummel, M., Araujo, I., Latza, U., Rancso, C., Dallenbach, F. & Stein, H. (1994) Patterns of cytokine gene expression in infectious mononucleosis. Blood, 83, 707-712.
18. Hallee, T.J., Evans, A.S., Niederman, J.C., Brooks, C.M. & Voegtly, J. (1974) Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years. Yale Journal of Biological Medicine, 47, 182-195.
19. Joncas, J., Monczak, Y., Ghibu, F., Alfieri, C., Bonin, A., Ahronheim, G. & Rivard, G. (1989) Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection. Journal of Medical Virology, 28, 110-117.
20. Kogawa, K., Lee, S. M., Villanueva, J., Marmer, D., Sumegi, J. & Filipovich, A.H. (2002) Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood, 99, 61-66.
21. Lanier, L.L., Le, A.M., Civin, C.I., Loken, M.R. & Phillips, J.H. (1986) The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. Journal of Immunology, 136, 4480-4486.
22. Lee, S.H., Girard, S., Macina, D., Busa, M., Zafer, A., Belouchi, A., Gros, P. & Vidai, S.M. (2001) Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nature Genetics, 28, 42-45.
23. Lee, P.T., Putnam, A., Benlagha, K., Teyton, L., Gottlieb, P.A. & Bencelac, A. (2002) Testing the NKT cell hypothesis of human IDDM pathogenesis. Journal of Clinical Investigation, 110, 793-800.
24. Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T.I., Bushkin, Y., Davis, D.M., Strominger, J.L., Yewdell, J.W. & Porgador, A. (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature, 409, 1055-1060.
25. Merino, F., Klein, G.O., Henle, W., Ramirez-Duque, P., Forsgren, M. & Amesty, C. (1983) Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome. Clinical Immunology and Immunopathology, 27, 326-339.
26. Moretta, A., Bottino, C., Mingari, M.C., Biassoni, R. & Moretta, L. (2002) What is a natural killer cell? Nature Immunology, 3, 6-8.
27. Nakajima, H., Cella, M., Langen, H., Friedlein, A. & Colonna, M. (1999) Activating interactions in human NK cell recognition: the role of 2B4-CD48. European Journal of Immunology, 29, 1676-1683.
28. Niederman, J.C., Evans, A.S., Subrahmanyan, L. & McCollum, R.W. (1970) Prevalence, incidence and persistence of EB virus antibody in young adults. New England Journal of Medicine, 282, 361-365.
29. Orange, J.S., & Biron, C.A. (1996) Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. Journal of Immunology, 156, 4746-4756.
30. Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, H.D., Wolf, H., Bonnefoy, J.Y., Biassoni, R., Moretta, L., Notarangelo, L.D. & Moretta, A. (2000) X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. Journal of Experimental Medicine, 192, 337-346.
31. Prussin, C. & Foster, B. (1997) TCR V alpha 24 and V beta 11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. Journal of Immunology, 159, 5862-5870.
32. Rickinson, A.B., Callan, M.F. & Annels, N.E. (2000) T-cell memory: lessons from Epstein-Barr virus infection in man. Philosophical Transactions of the Royal Society London B Biological Sciences, 355, 391-400.
33. Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M.G., Oettgen, H., de Vries, J.E., Aversa, G. & Terhorst, C. (1998) The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature, 395, 462-469.
34. Shilling, H.G., Young, N., Guethlein, L.A., Cheng, N.W., Gardiner, C.M., Tyan, D. & Parham, P. (2002) Genetic control of human NK cell repertoire. Journal of Immunology, 169, 239-247.
35. Shimizu, Y., Geraghty, D.E., Koller, B.H., Orr, H.T. & De Mars, R. (1988) Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proceedings of the National Academy of Science, USA, 85, 227-231.
36. Stevens, S.J., Vervoort, M.B., Van Den Brule, A.J., Meenhorst, P.L., Meijer, C.J. & Middeldorp, J.M. (1999) Monitoring of Epstein-Barr virus DNA load in peripheral blood by quantitative competitive PCR. Journal of Clinical Microbiology, 37, 2852-2857.
37. Tangye, S.G., Phillips, J.H., Lanier, L.L. & Nichols, K.E. (2000) Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. Journal of Immunology, 165, 2932-2936.
38. Thorley-Lawson, D.A., Ianelli, C., Klaman, L.D., Staunton, D. & Yokoyama, S. (1993) Function of CD48 and its regulation by Epstein-Barr virus. Biochemical Society Transactions, 21, 976-980.
39. Tomkinson, B.E., Wagner, O.K., Nelson, D.L. & Sullivan, J.L. (1987) Activated lymphocytes during acute Epstein-Barr virus infection. Journal of Immunology, 139, 3802-3807.
40. Uhrberg, M., Valiante, N.M., Shum, B.P., Shilling, H.G., Lienert-Weidenbach, K., Corliss, B., Tyan, D., Lanier, L.L. & Parham, P. (1997) Human diversity in killer cell inhibitory receptor genes. Immunity, 7, 753-763.
41. Valiante, N.M. & Trinchieri, G. (1993) Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. Journal of Experimental Medicine, 178, 1397-1406.
42. Williams, M.L., Loughran, T.P. Jr., Kidd, P.G., Starkebaum, G.A. (1989) Polyclonal proliferation of activated suppressor/cytotoxic T cells with transient depression of natural killer cell function in acute infectious mononucleosis. Clinical and Experimental Immunology, 77, 71-76.
43. Williams, H, Macsween, K., McAulay, K., Higgins, C., Swerdlow, A., Britton, K. & Crawford, D.H. (2004) Analysis of immune activation and clinical events in acute infectious mononucleosis. Journal of Infectious Diseases, 190, 63-71.